22.11.2012 Aufrufe

FORTSCHRITTSBERICHT JAHR 2006 - Helmholtz-Zentrum für ...

FORTSCHRITTSBERICHT JAHR 2006 - Helmholtz-Zentrum für ...

FORTSCHRITTSBERICHT JAHR 2006 - Helmholtz-Zentrum für ...

MEHR ANZEIGEN
WENIGER ANZEIGEN

Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.

YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.

Entwicklungen auf <strong>Zentrum</strong>sebene<br />

RG Cellular Proteomics<br />

Head: Dr. Lothar Jänsch<br />

Using Listeria monocytogenes as a model system for bacterial pathogens, an interdisciplinary<br />

approach of proteome research, genomics and bioinformatics is used to define the interactions<br />

between Listeria monocytogenes and its host cells at the molecular level. This includes protein<br />

interaction- and signalling-studies of virulence factors as well as a search for hitherto<br />

uncharacterised proteins directly involved in the infection cycle.<br />

JRG Immunodynamics (ID)<br />

Head: Dr. Matthias Gunzer<br />

The group addresses the cellular dynamics of immunological processes. The ultimate goal is<br />

to visualise living immune cells within their natural environment. On the one hand this means<br />

all the processes of communication between antigen presenting cells and naive T cells during<br />

the induction phase of a cellular immune response within lymphatic tissues. On the other hand<br />

the group aims to visualise the activity of immune cells during the defence against an infection<br />

or tumor immune surveillance and rejection. By visualising these events in vivo, the research<br />

group intends to understand the normal cellular dynamics of immunological processes<br />

as well as their alteration in the case of infection and disease.<br />

JRG Conformational Protein-Ligand Interactions (KPLI)<br />

Head: PD Dr. Jutta Eichler<br />

The research focus in this group is on the development and implementation of a general strategy<br />

for the inhibition of protein-ligand interactions through synthetic molecules mimicking<br />

conformationally defined protein binding sites. The synthesis concept for such inhibitors involves<br />

“rational design”, based on the known structure of the protein binding sites, in conjunction<br />

with the use of scaffolded or assembled peptides as binding site mimetics. Current<br />

projects aim at mimicking the binding site of the transmembrane receptor gp130 for viral interleukin-6,<br />

the CD4 binding site of the HIV-1 envelope glycoprotein gp120, as well as the<br />

binding site of the Spike protein of SARS CoV for its cellular receptor ACE2.<br />

JRG Chronic Pseudomonas diseases (CPI)<br />

Head: PD Dr. Susanne Häußler<br />

Pseudomonas aeruginosa has emerged as a major human opportunistic pathogen and represents<br />

a significant source for life-threatening nosocomial infections. The group studies the<br />

molecular mechanisms underlying bacterial adaptation processes to a chronic, persistent state<br />

of infection. In this context the group is working on the molecular mechanisms responsible<br />

for the switch from planctonic growth to a biofilm phenotype, on the role of interbacterial<br />

communication in persistent disease, and on the optimization and establishment of new methods<br />

in the microbiological diagnostics of CF specimens.<br />

49

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!